|17.40|| +0.02 / +0.12%|
Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through the following segments: Bioscience, Hospital, Diagnostic and Raw Materials. The Bioscience segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic segment includes the marketing of diagnostic testing equipment, reagents, and other equipment. The Raw Materials segment includes the sale of intermediate biological products and the rendering of manufacturing services to third party companies. Grifols was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
|Raimon Grifols Roura||Joint Chief Executive Officer & Director|
|Victor Grifols Deu||Joint Chief Executive Officer & Director|
|Alfredo Arroyo Guerra||Chief Financial Officer & Vice President|
|Vicente Blanquer Torre||Vice President-Quality, Research & Development|
|Eva Bastida Tubau||VP, Director-Scientific & Medical Affairs|